Vanguard Capital Wealth Advisors

Holdings History for Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT)

Symbol: SRPT on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2024		-0.27%	$0	0	-2,485	-100%	$18.50	Q3 2024
30 Jun 2024	0.27%	+0%	$392,630	2,485	+35	+1.4%	$158.00	Q2 2024
31 Mar 2024	0.22%	0%	$317,177	2,450	0		$129.46	Q1 2024
31 Dec 2023	0.19%	+0.01%	$236,254	2,450	+90	+3.8%	$96.43	Q4 2023
30 Sep 2023	0.27%	+0%	$286,079	2,360	+10	+0.43%	$121.22	Q3 2023
30 Jun 2023	0.24%	0%	$269,122	2,350	0		$114.52	Q2 2023
31 Mar 2023	0.32%	0%	$323,901	2,350	0		$137.83	Q1 2023
31 Dec 2022	0.35%	0%	$304,513	2,350	0		$129.58	Q4 2022
30 Sep 2022	0.32%	+0.32%	$260,000	2,350	+2,350	NEW	$110.64	Q3 2022
31 Mar 2022		-0.16%	$0	0	-2,400	-100%	$18.50	Q1 2022
31 Dec 2021	0.16%	0%	$216,000	2,400	0		$90.00	Q4 2021
30 Sep 2021	0.17%	+0.17%	$222,000	2,400	+2,400	NEW	$92.50	Q3 2021
31 Mar 2021		-0.68%	$0	0	-4,250	-100%	$18.50	Q1 2021
31 Dec 2020	0.68%	-0.05%	$729,000	4,250	-300	-6.6%	$171.53	Q4 2020
30 Jun 2020	0.87%	-0.06%	$729,000	4,550	-300	-6.2%	$160.22	Q2 2020
31 Dec 2019	0.67%	+0.09%	$625,000	4,850	+650	+15%	$128.87	Q4 2019
30 Sep 2019	0.37%	-0.04%	$316,000	4,200	-500	-11%	$75.24	Q3 2019
30 Jun 2019	0.86%	0%	$714,000	4,700	0		$151.91	Q2 2019
31 Mar 2019	0.74%	0%	$560,000	4,700	0		$119.15	Q1 2019
31 Dec 2018	0.76%	-0.03%	$512,000	4,700	-200	-4.1%	$108.94	Q4 2018
30 Sep 2018	0.95%	0%	$791,000	4,900	0		$161.43	Q3 2018
30 Jun 2018	0.9%	-0.02%	$647,000	4,900	-100	-2%	$132.04	Q2 2018
31 Mar 2018	0.47%	-0.03%	$358,650	5,000	-300	-5.7%	$71.73	Q1 2018
31 Dec 2017	0.38%	0%	$294,892	5,300	0		$55.64	Q4 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.